SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-158321
Filing Date
2024-06-10
Accepted
2024-06-10 16:05:55
Documents
13
Period of Report
2024-06-07
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d837508d8k.htm   iXBRL 8-K 28937
  Complete submission text file 0001193125-24-158321.txt   158518

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ikna-20240607.xsd EX-101.SCH 2869
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ikna-20240607_lab.xml EX-101.LAB 19501
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ikna-20240607_pre.xml EX-101.PRE 12169
16 EXTRACTED XBRL INSTANCE DOCUMENT d837508d8k_htm.xml XML 3909
Mailing Address 50 NORTHERN AVE. BOSTON MA 02210
Business Address 50 NORTHERN AVE. BOSTON MA 02210 857-343-8292
Ikena Oncology, Inc. (Filer) CIK: 0001835579 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40287 | Film No.: 241032691
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)